SSPLAXIndustrial Biotech
Precision fermentation, bio-based products and materials, and biology-enabled manufacturing.
Fermentation Scale-Up
Which stage sets the scale-up ceiling, and which single intervention creates the first real increase in saleable output?
A fermentation platform is moving from demonstrated production into commercial scale. The qualified base process and an intensified route both feed shared downstream recovery and product finishing. Leadership can advance one near-term scale-up move: add another fermentation campaign, debottleneck recovery, or secure external upstream capacity.
Bio-Based MaterialsUnit Economics
Which production mix reaches commercial volume and product requirements at the lowest modeled unit cost?
A bio-based materials company has a 1,000-tonne quarterly commitment. Internal production is qualified but capacity-limited; toll production is available at a premium. Lower-cost filler and bridge inputs can close the volume gap, but each carries a different effect on bio-based content, product performance, and carbon.
Capacity StrategyCapex Allocation
Which capacity moves should receive funding now, and which major build should remain deferred?
An industrial-biotechnology company has qualified demand ahead of installed production capacity. Leadership is comparing a near-term toll reservation, a second external partner, downstream debottlenecking, a brownfield production train, and a modular owned facility. Several moves require shared readiness investments, and the organization can execute only three major projects in the current cycle.